Emerging Next-Generation Target for Cancer Immunotherapy Research: The Orphan Nuclear Receptor NR2F6

SIMPLE SUMMARY: The most successful strategies for solid cancer immunotherapy have centered on targeting the co-stimulatory and co-inhibitory T cell molecules that regulate T cell activation. Although immunotherapy that targets surface receptors such as CTLA-4 and/or PD-1 with recombinant antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Klepsch, Victoria, Siegmund, Kerstin, Baier, Gottfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197903/
https://www.ncbi.nlm.nih.gov/pubmed/34073258
http://dx.doi.org/10.3390/cancers13112600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197903/
https://www.ncbi.nlm.nih.gov/pubmed/34073258
http://dx.doi.org/10.3390/cancers13112600

Ejemplares similares